Prior to joining M.M. Dillon & Co. in 2009, which was also previously known as CRT Investment Banking, Olivier served as a Managing Director at CRT Capital Group. Prior to joining CRT Capital Group, Olivier was the founder and CEO of 5 Gems Strategic Advisory. In 2001, he co-founded and served as CTO of Aureon Biosciences, a service laboratory in the space of predictive and personalized cancer focused clinical diagnostics and prognostics. Prior to Aureon, Olivier served for seven years as Director of Strategy and Architecture and CIO at JCDecaux, an international multi-billion dollar French conglomerate. In addition to his role at M.M. Dillon & Co, Dr. Saidi is currently Vice-Chair for Clinical and Healthcare Effectiveness at Mount Sinai Hospital.